T/CGCPU 002-2023 Active Group standards

T/CGCPU 002-2023 The standard for centralized management and evaluation of clinical trial drugs

T/CGCPU 002-2023 The standard for centralized management and evaluation of clinical trial drugs

Publish Date: 2023-01-01 Implement Date: 2023-01-10 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CGCPU 002-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Terminology (principles and coordination and cooperation)
Publish Date: 2023-01-01
Implement Date: 2023-01-10

Scope

Main technical content: Foreword Introduction 1 Scope 2 Normative reference documents 3 Terms and definitions, abbreviations 4 Evaluation content 4.1 Evaluation of centralized management of drugs used in clinical trials 4.2 Evaluation of satellite pharmacies for drugs used in clinical trials 5 Evaluation experts 6 Evaluation process 7 Result assessment 7.1 Evaluation conditions 7.2 Evaluation clauses 7.3 Evaluation conclusions Appendix A (Normative) Evaluation content of centralized management of drugs used in clinical trials Appendix B (Normative) Evaluation content of satellite pharmacies for drugs used in clinical trials Appendix C (Normative) Specific requirements for evaluation expert groups References

Development Information

Related Standards

Contact Us